Marc Ladanyi on Twitter: "Great to run into Emmet Jordan, first author of paper reporting #MSKimpact experience in #lungcancer (see: https://t.co/9qXVZDexpZ), now at Univ Hosp Waterford, here in Dublin for the Launch
![Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy - Jordan - Journal of Gastrointestinal Oncology Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy - Jordan - Journal of Gastrointestinal Oncology](https://cdn.amegroups.cn/journals/pbpc/files/journals/1/articles/15152/public/15152-PB10-R1.png/w300)
Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy - Jordan - Journal of Gastrointestinal Oncology
![1861898629 NPI Number | EMMET JORDAN | NEW YORK, NY | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2021 1861898629 NPI Number | EMMET JORDAN | NEW YORK, NY | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2021](https://www.hipaaspace.com/medical_billing/coding/national_provider_identifier/codes/npi_1861898629.png)
1861898629 NPI Number | EMMET JORDAN | NEW YORK, NY | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2021
![Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance | Clinical Cancer Research Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance | Clinical Cancer Research](https://clincancerres.aacrjournals.org/sites/default/files/highwire/clincanres/24/13.cover-source.jpg)